Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
CRBU
#3635
Caribou Biosciences, Inc. Common Stock
2.1
2
USD
+8.72%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
+8.72%
Changement Mensuel
+12.17%
Evolution sur 6 mois
-14.17%
Changement Annuel
+165.00%
Clôture Précédente
1.9
5
Open
2.1
2
Bid
Ask
Low
2.1
2
High
2.1
2
Volume
21
Marchés
Actions des Marchés US
Soins de Santé
CRBU
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
60.66 M
61.3 M
90.31 M
93 M
96.64 M
—
Valuation ratios
Enterprise value
674.99 M
374.6 M
479.37 M
158.09 M
141.29 M
495.57 M
Price to earnings ratio
—
-4.03
-4.04
-0.96
-1
-3.64
Price to sales ratio
—
29.02
11.92
14.37
13.31
57.51
Price to cash flow ratio
—
-4.42
-4.41
-1.04
-1.34
-4.52
Price to book ratio
—
1.34
1.12
0.57
1.22
1.69
Enterprise value to EBITDA ratio
-10.23
-3.31
-4.02
-0.81
-0.98
-3.23
Profitability ratios
Return on assets %
-0.15
-0.27
-0.24
-0.48
-0.84
-0.68
Return on equity %
-0.17
-0.33
-0.28
-0.59
-1.21
-0.92
Return on invested capital %
-449.68
-462.21
-419.33
-680.35
-897.62
-1 206.88
Gross margin %
100
100
100
100
100
400
Operating margin %
-697.84
-768.17
-336.63
-1 667.16
-1 329.37
-5 667.26
EBITDA margin %
-687.59
-756.46
-326.4
-1 627.87
-1 296.7
-5 527.98
Net margin %
-697.26
-717.79
-296.05
-1 491.95
-1 327.4
-5 653.43
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
15.15
9.25
11.97
7.16
5.71
25.55
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.02
0.03
0.09
0.03
0.05
0.05
Solvency ratios
Debt to assets ratio
0
0.07
0.06
0.08
—
—
Debt to equity ratio
0
0.09
0.07
0.1
—
—
Long term debt to total assets ratio
0
0
0
0
—
—
Long term debt to total equity ratio
0
0
0
0
—
—
Per share metrics
Operating cash flow per share
—
-1.5
-1.26
-1.53
-1.19
-1.19
EBIT per share
—
-1.75
-1.57
-1.84
-1.59
-1.59
EBITDA per share
—
-1.72
-1.52
-1.8
-1.55
-1.56
Total debt per share
—
0.46
0.37
0.29
—
—
Cash per share
—
5.21
5.05
2.76
1.53
7.51
Net current asset value per share
—
4.28
4.59
2.43
1.56
7.64
Tangible book value per share
—
4.95
4.99
2.8
1.31
6.96
Working capital per share
—
3.82
4.21
2.09
1.28
6.45
Book value per share
—
4.95
4.99
2.8
1.31
6.96
Nouvelles
Three Best Genomics Stocks for Your Portfolio in 2026
Sarepta Therapeutics (SRPT) Soars 35.0%: Is Further Upside Left in the Stock?
Caribou Biosciences: Antlers Up For The Allogenic CAR-T Bet Trading At Cash Value
Is CareCloud (CCLD) Outperforming Other Medical Stocks This Year?
Truist réitère sa recommandation d’achat sur Caribou Biosciences, objectif de 7$
Truist reiterates Buy on Caribou Biosciences stock, $7 target
Caribou Biosciences, Inc. (CRBU) Reports Q4 Loss, Tops Revenue Estimates
Le BPA de Caribou Biosciences a dépassé les attentes de 0,04$, le CA a surpassé les prévisions
Caribou Biosciences earnings beat by $0.04, revenue topped estimates
EyePoint (EYPT) Reports Q4 Loss, Tops Revenue Estimates
Urogen Pharma (URGN) Reports Q4 Loss, Beats Revenue Estimates
Syndax Pharmaceuticals (SNDX) Reports Q4 Loss, Tops Revenue Estimates